Isoprostanes and isofurans as non-traditional risk factors for cardiovascular disease among Canadian Inuit

References

• Singh U, Jialal I. Oxidative stress and atherosclerosis. Pathophysiology 2006; 13:129–142.
   PubMedGoogle Scholar
• Stocker R, Keaney JF Jr. Role of oxidative modifications in atherosclerosis. Physiol Rev 2004; 84:1381–1478.
   PubMed Web of Science ®Google Scholar
• Morrow JD. Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans. Arterioscler Thromb Vasc Biol 2005; 25:279–286.
   PubMed Web of Science ®Google Scholar
• Morrow JD. Is oxidant stress a connection between obesity and atherosclerosis? Arterioscler Thromb Vasc Biol 2003; 23: 368–370.
   PubMed Web of Science ®Google Scholar
• Stephens JW, Khanolkar MP, Bain SC. The biological relevance and measurement of plasma markers of oxidative stress in diabetes and cardiovascular disease. Atherosclerosis 2009; 202:321–329.
   PubMed Web of Science ®Google Scholar
• Milne GL, Yin H, Brooks JD, Sanchez S ,Roberts JL 2nd, Morrow JD. Quantification of F2-isoprostanes in biological fluids and tissues as a measure of oxidant stress. Meth Enzymol 2007; 433:113–126.
   PubMed Web of Science ®Google Scholar
• Keaney JF Jr, Larson MG, Vasan RS, Wilson PW, Lipinska I, Corey D, Massaro JM, . Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol 2003; 23:434–439.
   PubMed Web of Science ®Google Scholar
• Hou X, Roberts LJ 2nd , Gobeil F, Taber D Jr, Kanai K, Abran D, . Isomer-specific contractile effects of a series of synthetic f2-isoprostanes on retinal and cerebral microvasculature. Free Radic Biol Med 2004; 36:163–172.
   PubMed Web of Science ®Google Scholar
• Basu S. F2-isoprostane induced prostaglandin formation in the rabbit. Free Radic Res 2004; 40:273–277.
   Web of Science ®Google Scholar
• Minuz P, Patrignani P, Gaino S, Degan M, Menapace L, Tommasoli R, . Increased oxidative stress and platelet activation in patients with hypertension and renovascular disease. Circulation 2002; 106:2800–2805.
   PubMed Web of Science ®Google Scholar
• Brault S. Selective neuromicrovascular endothelial cell death by 8-Iso-prostaglandin F2alpha: possible role in ischemic brain injury. Stroke 2003; 34:776–782.
   PubMed Web of Science ®Google Scholar
• Roberts LJ 2nd, Fessel JP. The biochemistry of the isoprostane, neuroprostane, and isofuran pathways of lipid peroxidation. Chem Phys Lipids 2004; 128:173–186.
   PubMed Web of Science ®Google Scholar
• Bjerregaard P, Young TK, Dewailly E, Ebbesson SO. Indigenous health in the Arctic: an overview of the circumpolar Inuit population. Scand J Publ Health 2004; 32:390–395.
   PubMed Web of Science ®Google Scholar
• Bjerregaard P, Dewailly E, Young TK, Blanchet C, Hegele RA, Ebbesson SE, . Blood pressure among the Inuit (Eskimo) populations in the Arctic. Scand J Publ Health 2003; 31: 92–99.
   PubMed Web of Science ®Google Scholar
• Young TK, Bjerregaard P, Dewailly E, Risica PM, Jorgensen ME, Ebbesson SE. Prevalence of obesity and its metabolic correlates among the circumpolar Inuit in 3 countries. Am J Publ Health 2007; 97:691–695.
   PubMed Web of Science ®Google Scholar
• Bjerregaard P, Young TK, Dewailly E, Ebbesson SE. Review Article: Indigenous health in the Arctic: an overview of the circumpolar Inuit population. Scand J Publ Health 2004; 32: 390–395.
   PubMed Web of Science ®Google Scholar
• Egeland GM, Cao Z, Young TK. Hypertriglyceridemic-waist phenotype and glucose intolerance among Canadian Inuit: the International Polar Year Inuit Health Survey for Adults 2007–2008. CMAJ 2011; 183:E553–E558.
   PubMed Web of Science ®Google Scholar
• Alberti KGMM, Eckel, RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, . Harmonizing the metabolic syndrome. Circulation 2009; 120:1640–1645.
   PubMed Web of Science ®Google Scholar
• Grundy SM, Hansen BS, Sidney CC, James I, Kahn RA. Clinical management of metabolic syndrome. Circulation 2004; 109:551–556.
   PubMed Web of Science ®Google Scholar
• Morrow JD, Roberts LJ 2nd. Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as measure of oxidant stress. Meth Enzymol 1999; 300:3–12.
   PubMed Web of Science ®Google Scholar
• Lemieux I, Poirier P, Bergeron J, Almeras N, Lamarche B, Cantin B, . Hypertriglyceridemic waist: A useful screening phenotype in preventive cardiology? Can J Cardiol 2007; 23: 23B–31B.
   PubMed Web of Science ®Google Scholar
• Arsenault BJ, Lemieux I, Despres JP, Wareham NJ, Kastelein JJ P, Khaw KT, Boekholdt SM. The hypertriglyceridemic-waist phenotype and the risk of coronary artery disease: results from the EPIC-Norfolk Prospective Population Study. CMAJ 2010; 182:1427–1432.
   PubMed Web of Science ®Google Scholar
• Pou KM, Massaro JM, Hoffmann U, Vasan RS, Maurovich-Horvat P, Larson MG, . Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: The Framingham Heart Study. Circulation 2007; 116:1234–1241.
   PubMed Web of Science ®Google Scholar
• Forouhi NG, Sattar N, McKeigue PM. Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians. Int J Obes Relat Metab Disord 2001; 25:1327–1331.
   PubMed Web of Science ®Google Scholar
• Brooks GC, MJ Blaha, Blumenthal RS. Relation of C-reactive protein to abdominal adiposity. Am J Cardiol 2010; 106:56–61.
   PubMed Web of Science ®Google Scholar
• Handelman GJ, Walter MF, Adhikarla RG, Jonathan D, Gerard EL, Nathan WB, Jeffrey B. Elevated plasma F2-isoprostanes in patients on long-term hemodialysis. Kidney Int 2001; 59: 1960–1966.
   PubMed Web of Science ®Google Scholar
• Cheung BMY, Ong KL, Tso AWK, Leung RYH, Xu A, Cherny SS, . C-reactive protein as a predictor of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study (CRISPS) cohort. J Hum Hypertens 2012; 26:108–116.
   PubMed Web of Science ®Google Scholar
• Lavi S, Yang EH, Prasad A, Mathew V, Barsness GW, Rihal CS, . The interaction between coronary endothelial dysfunction, local oxidative stress, and endogenous nitric oxide in humans. Hypertension 2008; 51:127–133.
   PubMed Web of Science ®Google Scholar
• Szmitko PE, Szmitko PE, Wang CH, Weisel RD, de Almeida JR, Anderson TJ, Verma S. New markers of inflammation and endothelial cell activation. Circulation 2003; 108:1917–1923.
   PubMed Web of Science ®Google Scholar
• Ghanem FA, Movahed A. Inflammation in high blood pressure: a clinician perspective. J Am Soc of Hypertens 2007; 1:113–119.
   PubMed Web of Science ®Google Scholar
• Morrow JD, Frei B, Longmire AW, Gaziano, JM, Lynch SM, Shyr Y, . Increase in circulating products of lipid peroxidation (F2-Isoprostanes) in smokers舘 smoking as a cause of oxidative damage. N Eng J Med 1995; 332:1198–1203.
   PubMed Web of Science ®Google Scholar
• Helmersson J, Larsson A, Vessby B, Basu S. Active smoking and a history of smoking are associated with enhanced prostaglandin F (2alpha), interleukin-6 and F2-isoprostane formation in elderly men. Atherosclerosis 2005; 181:201–207.
   PubMed Web of Science ®Google Scholar
• Dietrich M, Block G, Hudes M, Morrow JD, Norkus EP, Traber MG, . Factors associated with oxidative stress in human populations. Am J Epidemiol 2002; 156:274–285.
   PubMed Web of Science ®Google Scholar
• Ward NC, Hodgson JM, Puddey IB, Mori TA, Beilin LJ, Croft, KD. Oxidative stress in human hypertension: association with antihypertensive treatment, gender, nutrition, and lifestyle. Free Radic Biol Med 2004; 36:226–232.
   PubMed Web of Science ®Google Scholar
• Il’yasova D, Morrow JD, Wagenknecht LE. Urinary F2-isoprostanes are not associated with increased risk of type 2 diabetes. Obes Res 2005; 13:1638–1644.
   PubMedGoogle Scholar
• Sørensen LT, Jorgensen S, Petersen LJ, Hemmingsen UB low JL, Steffen GF. Acute effects of nicotine and smoking on blood flow, tissue oxygen, and aerobe metabolism of the skin and subcutis. J Surg Res 2009; 152:224–230.
   PubMed Web of Science ®Google Scholar
• Jensen J, Arthur G, William HH, Harriet WH, Thomas K. Cigarette Smoking Decreases Tissue Oxygen. Arch Surg 1991; 126:1131–1134.
   PubMed Web of Science ®Google Scholar
• Belanger MC, Dewailly E, Berthiaume L, Noel M, Bergeron J, Mirault ME, Julien P. Dietary contaminants and oxidative stress in Inuit of Nunavik. Metabolism 2006; 55:989–995.
   Web of Science ®Google Scholar
• Hansel B, Giral P, Nobecourt E, Chantepie S, Bruckert E, Chapman MJ, Kontush A. Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. J Clin Endocrinol Metab 2004; 89: 4963–4971.
   PubMed Web of Science ®Google Scholar
• Gross MS, Michael J, David R Jr, Yu X, Lewis L, Lewis CE, Loria CM. Plasma F2-Isoprostanes and Coronary Artery Calcification: The CARDIA Study. Clin Chem 2005; 51: 125–131.
   PubMed Web of Science ®Google Scholar
• Mosca L, Appel LJ, Benjamin EJ, Berra K, Chandra-Strobos N, Fabunmi P, . Evidence-based guidelines for cardiovascular disease prevention in women. J Am Coll Cardiol 2004; 43:900–921.
   PubMed Web of Science ®Google Scholar
• Zhou YE, Kubow S, Egeland GE. Highly unsaturated n-3 fatty acids status of Canadian Inuit: International Polar Year Inuit Health Survey, 2007–2008. Int J Circumpolar Health 2011; 70:498–510.
   PubMed Web of Science ®Google Scholar